Cancer Treatment-Induced Accelerated Aging in Cancer Survivors: Biology and Assessment
Rapid improvements in cancer survival led to the realization that many modalities used to treat or control cancer may cause accelerated aging in cancer survivors. Clinically, “accelerated aging” phenotypes in cancer survivors include secondary cancers, frailty, chronic organ dysfunction, and cogniti...
Main Authors: | Shuo Wang, Anna Prizment, Bharat Thyagarajan, Anne Blaes |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/3/427 |
Similar Items
-
Accelerated Aging in Cancer Survivors: Cellular Senescence, Frailty, and Possible Opportunities for Interventions
by: Shuo Wang, et al.
Published: (2024-03-01) -
Doxycycline Attenuated Ethanol-Induced Inflammaging in Endothelial Cells: Implications in Alcohol-Mediated Vascular Diseases
by: Xuanchen Li, et al.
Published: (2022-12-01) -
Skin-Aging Pigmentation: Who Is the Real Enemy?
by: Jin Cheol Kim, et al.
Published: (2022-08-01) -
Aging of mesenchymal stem cell: machinery, markers, and strategies of fighting
by: Mahmoud Al-Azab, et al.
Published: (2022-08-01) -
Biological Aspects of Inflamm-Aging in Childhood Cancer Survivors
by: Francesca Rossi, et al.
Published: (2021-09-01)